XML 76 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Jan. 01, 2022
Cash flows from operating activities:      
Net income $ 81.5 $ 143.5 $ 229.6
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 98.3 136.1 35.6
Stock-based compensation 7.0 47.7 44.7
Amortization of debt issuance costs 1.9 1.4 0.0
Loss on disposal of equipment, intangibles and other assets 0.8 0.5 0.5
Provision for credit losses 1.1 1.3 0.8
Benefit from deferred income taxes (35.6) (39.3) (15.1)
Impairment charge 10.0 0.0 0.0
Changes in operating assets and liabilities:      
(Increase) decrease in trade accounts receivable 90.2 (138.5) (60.8)
(Increase) decrease in inventories (69.2) (155.9) 13.5
(Increase) decrease in other current assets (8.6) (7.4) 6.9
(Increase) decrease in lease receivable, net 1.7 (12.8) (16.1)
(Increase) decrease in deferred costs and other contract assets (14.4) (13.4) (8.1)
(Increase) decrease in other non-current assets 3.0 (4.9) 0.0
Increase (decrease) in accounts payable (19.6) 60.5 11.0
Increase (decrease) in accrued compensation (26.8) (9.3) 0.0
Increase (decrease) in deferred revenue and other contract-related liabilities 7.1 28.1 7.1
Increase (decrease) in income taxes payable (15.1) 3.8 6.4
Increase (decrease) in accrued liabilities (22.8) (16.1) 7.8
Increase (decrease) in other non-current liabilities 3.6 4.1 0.8
Net cash provided by (used in) operating activities 94.1 29.4 264.6
Cash flows from investing activities:      
Purchases of property and equipment, net (44.0) (52.8) (25.5)
Increase in intangible assets (43.7) (3.5) (9.4)
Business combinations, net of cash acquired 7.5 (999.7) 0.0
Other strategic investing activities (1.0) (1.7) (2.6)
Net cash (used in) provided by investing activities (81.2) (1,057.7) (37.5)
Cash flows from financing activities:      
Borrowings under revolving line of credit 189.0 1,083.9 0.0
Repayments under revolving line of credit (240.2) (135.4) 0.0
Proceeds from issuance of common stock 7.0 8.1 23.2
Repurchases of common stock 0.0 (401.5) (128.9)
Payroll tax withholdings on behalf of employees for stock options (12.9) (25.4) (16.7)
Debt issuance costs 0.0 (9.3) 0.0
Net cash (used in) provided by financing activities (57.1) 520.4 (122.4)
Effect of foreign currency exchange rates on cash 2.8 (30.9) (1.3)
Net increase in cash, cash equivalents and restricted cash (41.4) (538.8) 103.4
Cash, cash equivalents and restricted cash at beginning of period 209.6 748.4 645.0
Cash, cash equivalents and restricted cash at end of period $ 168.2 $ 209.6 $ 748.4